Europeiska unionen -
svenska -
EMA (European Medicines Agency)
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcell - antineoplastiska medel - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
carduran 8 mg depottablett
2care4 aps - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 8 mg depottablett
medartuum ab - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 8 mg depottablett
medartuum ab - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 8 mg depottablett
orifarm ab - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
carduran 8 mg depottablett
2care4 aps - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 8 mg depottablett
orifarm ab - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
carduran 8 mg depottablett
2care4 aps - doxazosinmesilat - depottablett - 8 mg - doxazosinmesilat 9,7 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 4 mg depottablett
omnia läkemedel ab - doxazosinmesilat - depottablett - 4 mg - doxazosinmesilat 4,85 mg aktiv substans - doxazosin
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cardura 4 mg depottablett
europharma sverige ab - doxazosinmesilat - depottablett - 4 mg - doxazosinmesilat 4,85 mg aktiv substans - doxazosin